Latest news for Delivery Hero (OTC:DELHY) Stock

Delivery Hero is an online food delivery provider and active delivery service headquartered in Germany. It operates in over 70 countries across five continents. Commission rate per order, the company's largest source of revenue, varies across the countries in its four geographic segments--the Americas, Asia, Europe, and the Middle East and North Africa--as well as the type of restaurant and the provided service.

DELIVERY HERO SE UNSP/ADR by Delivery Hero AG NA

Delivery Hero SE

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Truist Securities analyst Robyn Karnauskas downgraded the rating for Merck &amp; Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) from Buy to Hold and lowered the price target from $130 to $110. Merck shares closed at $101.02 on Tuesday. <a href="https://www.benzinga.com/quote/MRK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Goldman Sachs analyst Alex Scott downgraded American International Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>) from Buy to Neutral and lowered the price target from $83 to $79. American Intl shares closed at $72.59 on Tuesday. <a href="https://www.benzinga.com/quote/AIG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank analyst Brad Zelnick downgraded the rating for Palo Alto Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) from Buy to Hold and lowered the price target from $207 to $190. Palo Alto shares closed at $175.51 on Tuesday. <a href="https://www.benzinga.com/quote/PANW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Vikram Bagri downgraded the rating for SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) from Neutral to Sell and cut the price target from $12 to $9. SolarEdge Technologies shares closed at $17.59 on Tuesday. <a href="https://www.benzinga.com/quote/SEDG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank analyst Brad Zelnick downgraded Adobe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) from Buy to Hold and lowered the price target from $600 to $475. Adobe shares closed at $422.63 on Tuesday. <a href="https://www.benzinga.com/quote/ADBE/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ADBE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="589" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08071359/image-45-1024x589.png" alt="" class="wp-image-723790" style="width:567px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08071359/image-45-1024x589.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08071359/image-45-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08071359/image-45-768x441.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08071359/image-45.png 1082w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42846607/bank-of-new-york-mellon-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Bank of New York Mellon Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

News

Downgrades

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ADBE

PANW

SEDG

This Adobe Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Biotech

Health Care

General

TLSA

Tiziana Life Sciences Announced That A Review Article Was Published In Nature Reviews Neurology, Highlighting The Therapeutic Potential Of Intranasal Foralumab In Various Neurodegenerative Diseases

Barclays analyst Adrienne Yih upgrades Tapestry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) from Equal-Weight to Overweight and raises the price target from $57 to $87.

Upgrades

Price Target

Barclays Upgrades Tapestry to Overweight, Raises Price Target to $87

BSEM

Biostem Technologies Announces The Initiation Of The Br-am-dfu (bioretain Amniotic Membrane - Diabetic Foot Ulcers) Clinical Trial To Evaluate Vendaje Versus Standard Of Care For Patients Suffering With Non-healing Diabetic Foot Ulcers

Management believes that preliminary results reflect stronger-than-expected headwinds in the aesthetics industry, further intensified by broader macroeconomic challenges.&nbsp;

Guidance

INMD

InMode Expects Q4 Revenue Of $97.0M-$97.5M (Est $114.22M); Preliminary Results Reflect Stronger-than-Expected Headwinds In Aesthetics Industry

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

Jasper Therapeutics Reported Positive Preliminary Data From Jasper's Ongoing BEACON Phase 1b/2a Study Of Subcutaneous Briquilimab In Adult Participants With CSU

Piper Sandler analyst Paul Newsome upgrades Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) from Neutral to Overweight and raises the price target from $285 to $315.

Piper Sandler Upgrades Arthur J. Gallagher to Overweight, Raises Price Target to $315

JP Morgan analyst Marcelo Santos maintains MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) with a Neutral and lowers the price target from $2150 to $1950.

MELI

JP Morgan Maintains Neutral on MercadoLibre, Lowers Price Target to $1950

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

Currenc Group Announced The Launch Of Its Seamless Ai Call Centre Solutions, A Suite Of AI-powered Tools Designed To Reduce Costs, Increase Efficiency And Boost Customer Satisfaction

GRMN

Garmin Announced A New Montana Series – The Montana 710, Montana 710i And Robust Montana 760i – To Its Collection Of Handheld GPS Navigators

VK2375 is being developed in both oral and subcutaneous formulations for the potential treatment of various metabolic disorders such as obesity.

VKTX

Viking Therapeutics Initiates Phase 2 Clinical Trial Of The Oral Tablet Formulation Of VK2735

JMP Securities analyst Silvan Tuerkcan initiates coverage on Context Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTX#NASDAQ">CNTX</a>) with a Market Outperform rating and announces Price Target of $4.

Initiation

CNTX

JMP Securities Initiates Coverage On Context Therapeutics with Market Outperform Rating, Announces Price Target of $4

BFLY

Butterfly Network Announced That It Expects To Report Revenue Growth For The Fourth Quarter Ended December 31, 2024 Of Approximately 35% Year Over Year

<ul>
<li>Provides 2025 Annual Guidance of $178 - $182 Million in Revenue and $38 -&nbsp;$42 Million of Adjusted EBITDA, Representing Year-Over-Year Increase of 13% in Revenues and 19% in Adjusted EBITDA Based on Mid-Point of 2024 Annual Guidance</li>
<li>Expects to Achieve 2024 Guidance of $158 - $162 Million in Revenue and $32 - $35 Million of Adjusted EBITDA; 2024 Year-End Cash of $78 Million</li>
<li>Aiming to Secure New Business Development and M&amp;A Transactions During 2025 that Leverage Overall Financial Strength and Existing Commercial Infrastructure to Accelerate Long-Term Growth</li>
<li>Expansion of Plasma Collection Operations with Opening of a Third Center by End of Q1 2025</li>
<li>Based on Positive Feedback from U.S. FDA, Kamada Plans to Reduce Inhaled AAT Clinical Study Sample Size to Approximately 180 Patients; Interim Futility Analysis Planned by End of 2025</li>
</ul>

KMDA

Kamada Reaffirms 2024 Targets, Unveils 2025 Guidances, Revenue Of $178M-$182M Vs. $171.18M Est. And Adj.EBITDA Of $38M-$42M

The aggregate gross proceeds to uniQure from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by uniQure, are expected to be approximately $75 million.&nbsp;

Offerings

QURE

uniQure Prices Public Offering Of 4.41M Of Its Ordinary Shares At $17.00 Per Share

HALO

Halozyme Raises 2025 Financial Guidance Ranges For Total Revenue To $1.150B - $1.225B From $1.095B to $1.170B (Vs. Cons. Of $1.156B), Adj. EPS To $4.95 - $5.35 From $4.45 to $4.85 (Vs. Cons. $4.83)

As the planned purchases are to be executed by Wei Fu&nbsp;via his controlled entity, I-Mab cannot guarantee the number of ADSs to be purchased or the time frame in which the ADSs will be bought in the open market.

IMAB

I-Mab Chairman Wei Fu Informs His Intent To Purchase Up To $2M Of Company's American Depository Shares

The clinical program for sonelokimab now includes patients with adolescent hidradenitis suppurativa, palmoplantar pustulosis, and axial spondyloarthritis, in addition to adult patients with HS and active psoriatic arthritis.&nbsp;
This increases the number of clinical trials led by MoonLake to ten and aligns with the plan to enroll over 3,000 patients in clinical trials with sonelokimab since the Company was founded in 2021.

MLTX

MoonLake Immunotherapeutics Announced That Patients Have Been Screened In Three New Trials Across Three New Indications To Evaluate Sonelokimab To Treat Inflammatory Disease

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Piper Sandler analyst Clarke Jeffries upgraded the rating for Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) from Neutral to Overweight and raised the price target from $311 to $357. Autodesk shares closed at $290.82 on Tuesday. <a href="https://www.benzinga.com/quote/ADSK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank analyst Brian Bedell upgraded Nasdaq, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) from Hold to Buy and raised the price target from $80 to $98. Nasdaq shares closed at $76.36 on Tuesday. <a href="https://www.benzinga.com/quote/NDAQ/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst John Lovallo upgraded the rating for PulteGroup, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>) from Neutral to Buy but lowered the price target from $154 to $148. PulteGroup shares closed at $107.83 on Monday. <a href="https://www.benzinga.com/quote/PHM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Michael Sison upgraded RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) from Equal-Weight to Overweight and raised the price target from $134 to $140. RPM shares closed at $121.74 on Tuesday. <a href="https://www.benzinga.com/quote/RPM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho analyst Siti Panigrahi upgraded Twilio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) from Neutral to Outperform and raised the price target from $85 to $140. Twilio shares closed at $109.82 on Tuesday. <a href="https://www.benzinga.com/quote/TWLO/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying NDAQ stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="578" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08070637/image-44-1024x578.png" alt="" class="wp-image-723783" style="width:714px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08070637/image-44-1024x578.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08070637/image-44-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08070637/image-44-768x433.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08070637/image-44.png 1102w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42846607/bank-of-new-york-mellon-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Bank of New York Mellon Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

ADSK

NDAQ

TWLO

This Nasdaq Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Despite finding some footing in 2024, the lithium market's main concerns, oversupply and slower-than-expected <a target="_blank" href="https://www.benzinga.com/electric-vehicles" rel="noreferrer noopener">electric vehicle (EV) adoption</a> could persist this year.
"This swing supply dynamic could serve as a cap on price increases in 2025, as rapid restarts may lead to a more oversupplied market than currently forecast," Federico Gay, principal lithium analyst at Benchmark Mineral Intelligence said, according to the <a target="_blank" href="https://www.bnnbloomberg.ca/business/international/2025/01/08/stubbornly-resilient-lithium-supply-remains-hurdle-to-recovery/" rel="noreferrer noopener">BNN Bloomberg's report</a>.
Current analyst projections estimate lithium carbonate prices will stabilize around $10,685 per ton in 2025. As prices have dropped over 80% since 2022, the market's "invisible hand" stepped in.
Suspended outputs and delayed expansion plans helped lithium regain its footing, but significant rebounds remain unlikely.
BloombergNEF recently downgraded its EV adoption forecast, citing geopolitical and economic uncertainties.
Donald Trump's return to the U.S. presidency has shifted policy focus back to fossil fuels, which may further dampen demand for battery metals.
Despite these headwinds, China has solidified its position in the lithium market, raising its reserves from 6% to 16.5% of the global total, making it the second-largest global market.
New reserves include spodumene mines in Tibet and lithium salt lakes in the Qinghai-Tibet Plateau—now the third largest in the world. With a low-cost alternative, China aims to reduce reliance on imports and further strengthen its influence on the EV market.
Yet, the U.S. is quietly growing its reserves, with Nevada in the center.
Lithium Americas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAC#NYSE">LAC</a>) has significantly increased reserves at its Thacker Pass project near the Nevada-Oregon border, with proven and probable reserves jumping 286% (since 2022) to 14.3 million tons of lithium carbonate equivalent (LCE).
The project's expanded lifespan and increased capacity position it as a critical supplier for General Motors' EV production. Lithium Americas also appointed Luke Colton as CFO to guide the project's development, which is set to commence later this decade.
Meanwhile, Nevada Lithium's (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/NVLHF#OTCQB">NVLHF</a>) Bonnie Claire project has made remarkable progress. The company <a target="_blank" href="https://nevadalithium.com/news-release/nevada-lithium-to-commence-trading-on-tsx-venture-exchange/" rel="noreferrer noopener">announced</a> a 68% increase in inferred resources at its Lower Zone, now holding 25.6 Mt of LCE at an average grade of 3,085 ppm lithium.
This development represents a threefold improvement in grade compared to prior estimates, with additional high-grade boron resources adding further value. The company was recently listed on the Toronto Venture Stock Exchange, where it trades under the ticker NVLH.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/guidance/25/01/42840568/chiles-codelco-targets-turnaround-with-modest-copper-output-increase-and-strategic-lithium-ventures" target="_blank" rel="noreferrer noopener">Chile's Codelco Targets Turnaround with Modest Copper Output Increase and Strategic Lithium Ventures</a></li>
</ul>
Photo via Shutterstock

Commodities

Media

NVLHF

Lithium Woes Spillover Into 2025, But US And China Quietly Build Reserves

Delivery Hero SE: The Uber Deal Is Great News, But The Stock Is Not Cheap

Delivery Hero: Diverse And Robust Brand Portfolio

Deliveroo: Determining Potential Acquisition Price

Delivery Hero SE (DLVHF) Q2 2024 Earnings Call Transcript

Delivery Hero SE 2024 Q2 - Results - Earnings Call Presentation

Delivery Hero: Watch Out For The Big Middle Eastern Catalyst

Alphyn Capital Management Q3 2024 Letter To Investors

DLVHF Q3_2024_Slides

Delivery Hero SE (DLVHF) Q3 2024 Earnings Call Transcript

Uber's $950M purchase of Delivery Hero's Foodpanda business blocked by Taiwan

AMZN

BAMGF

BAMKF

BKAMF

BKFAF

BKFDF

BKFOF

BKFPF

BRCFF

BROXF

BRPSF

BXDIF

CCOI

DASH

DELHY

DLVHF

DROOF

EADSF

EADSY

FAXRF

FAXXF

FFHPF

FRFFF

FRFGF

FRFHF

FRFXF

FRFZF

FXFHF

FXFLF

GOOG

GOOGL

JTKWY

LUMN

MLSPF

MSFT

OCSL

PROSF

PROSY

RLLCF

RYCEF

RYCEY

SAFRF

SAFRY

STZHF

TCEHY

TCTZF

TKAYF

UBER

WANSF

Delivery Hero

Comments

Delivery Hero

News

Latest news for Delivery Hero (OTC:DELHY) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga